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Abstract
Background: Leishmania parasites are transmitted in the presence of sand fly saliva. Together with the parasite, the sand fly
injects biologically active salivary components that favorably change the environment at the feeding site. Exposure to bites
or to salivary proteins results in immunity specific to these components. Mice immunized with Phlebotomus papatasi
salivary gland homogenate (SGH) or pre-exposed to uninfected bites were protected against Leishmania major infection
delivered by needle inoculation with SGH or by infected sand fly bites. Immunization with individual salivary proteins of two
sand fly species protected mice from L. major infection. Here, we analyze the immune response to distinct salivary proteins
from P. papatasi that produced contrasting outcomes of L. major infection.
Methodology/Principal Findings: DNA immunization with distinct DTH-inducing salivary proteins from P. papatasi
modulates L. major infection. PpSP15-immunized mice (PpSP15-mice) show lasting protection while PpSP44-immunized
mice (PpSP44-mice) aggravate the infection, suggesting that immunization with these distinct molecules alters the course
of anti-Leishmania immunity. Two weeks post-infection, 31.5% of CD4
+ T cells produced IFN-c in PpSP15-mice compared to
7.1% in PpSP44-mice. Moreover, IL-4-producing cells were 3-fold higher in PpSP44-mice. At an earlier time point of two
hours after challenge with SGH and L. major, the expression profile of PpSP15-mice showed over 3-fold higher IFN-c and IL-
12-Rb2 and 20-fold lower IL-4 expression relative to PpSP44-mice, suggesting that salivary proteins differentially prime anti-
Leishmania immunity. This immune response is inducible by sand fly bites where PpSP15-mice showed a 3-fold higher IFN-c
and a 5-fold lower IL-4 expression compared with PpSP44-mice.
Conclusions/Significance: Immunization with two salivary proteins from P. papatasi, PpSP15 and PpSP44, produced distinct
immune profiles that correlated with resistance or susceptibility to Leishmania infection. The demonstration for the first
time that immunity to a defined salivary protein (PpSP44) results in disease enhancement stresses the importance of the
proper selection of vector-based vaccine candidates.
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Introduction
In leishmaniasis, phlebotomine sand flies transmit Leishmania
parasites to a mammalian host by depositing the parasite in the
skin during probing and feeding. Together with the parasite, sand
flies deposit a repertoire of salivary components that assist the sand
fly in getting a blood meal [1]. Some of these salivary proteins are
immunogenic in humans, canids and mice [2–5]. Repeated
exposure to sand fly salivary gland homogenate (SGH) or sand
fly bites have been shown to protect mice to subsequent challenge
with Leishmania major and SGH [6] or L. major infected sand flies
[7].
The protective effect of insect saliva is not exclusive to sand flies
and leishmaniasis. Animals pre-exposed to tick bites were
protected from Borrelia infection [8] and from the fatal outcome
of tularemia [9]. Moreover, immunization with a single tick
salivary protein protected mice from the fatal outcome of
encephalitis virus [10]. Furthermore, pre-exposure to mosquito
bites protected mice against Plasmodium berghei infection [11] and
more recently, immunization with the saliva of an aquatic insect
(Naucoris genus) protected animals against Mycobacterium ulcerans
infection [12].
To date, only two sand fly salivary proteins, Maxadilan from
Lutzomyia longipalpis and PpSP15 from Phlebotomus papatasi, have
shown promise as protective molecules against leishmaniasis
[13,14]. It is proposed that immunity to maxadilan neutralizes
exacerbation of L. major infection [13], while immunization with
PpSP15 results in protection of wild-type and B-cell deficient mice
www.plosntds.org 1 April 2008 | Volume 2 | Issue 4 | e226indicating that cellular immunity to PpSP15 is sufficient for
protection [14]. Moreover, the protection observed by immuni-
zation with PpSP15 was associated with a DTH response [14].
More recently, Oliveira et al. investigated the IgG isotypes
produced by DNA immunization with plasmids encoding distinct
DTH-inducing sand fly salivary proteins and showed that some
molecules produce IgG2a antibodies indicative of a Th1 response
while others surprisingly produced IgG1, a marker for Th2
response in mice [15].
In this work we identified two additional DTH-inducing salivary
proteins in P. papatasi, PpSP42 and PpSP44. Mice immunized with
either of these molecules were not protected against L. major
infection. Moreover, PpSP44-immunized mice showed aggravated
lesions. This allowed us to explore how immunity to specific
salivary proteins could affect the outcome of L. major infection. We
show for the first time that an early adaptive immune response
specific to a salivary protein is able to prime the anti-Leishmania
immune response leading to protection or exacerbation of L. major
infection. More importantly, this adaptive response is efficiently
elicited by sand fly bites, the natural route of transmission.
Methods
Sand fly rearing and exposure to animals
P. papatasi Israeli strain sand flies were reared at the Walter
Reed Army Medical Research Institute and at the Laboratory of
Malaria and Vector Research, NIAID, NIH, as described
elsewhere [14]. Preparation of salivary gland homogenate (SGH)
and pre-exposure of mice (Charles River Laboratories Inc) to
uninfected sand flies was carried out according to Valenzuela et al.
[14] and Kamhawi et al. [7]. Experiments were performed using 6
to 8 weeks old C57BL/6 mice under pathogen free conditions. All
animal studies were approved by the Animal Care and Use
Committee at The National Institute of Allergy and Infectious
Diseases.
Construction of P. papatasi salivary DNA plasmids and
immunization of mice
Ten DNA plasmids encoding to P. papatasi salivary gland-
secreted proteins were cloned into the VR2001-TOPO vector and
purified as previously described [15]. Mice were immunized
intradermally in the right ear three times at two weeks intervals
with 5 mg of DNA plasmid in 10 ml sterile water or with the
equivalent of 0.5 sand fly salivary gland pairs in 10 ml PBS [15].
Intradermal challenge with SGH and Leishmania
parasites
Two weeks after the last DNA immunization, animals were
challenged intradermally in the left ear with P. papatasi SGH (0.5
salivary gland pair/10 ml) to test for DTH inducing salivary
proteins. For infection, a mixture of 0.5 pairs SGH and 500 L
.major metacyclics in 10 ml (SGH-LM) was used to mimic the
natural route of transmission. L. major clone V1 (MHOM/IL/80/
Friedlin) was cultured in 199 medium with 10% heat-inactivated
fetal bovine serum (HyClone), 100 U/ml penicillin, 100 mg/ml
streptomycin, 2 mM L-glutamine and 40 mM Hepes.
Ear thickness and lesion size
The ear thickness was measured 48 hours following intradermal
injection of P. papatasi SGH. Values are represented as D ear
thickness (ear thickness of experimental groups subtracted from
the mean ear thickness of naı ¨ve mice 48 hours after injection with
0.5 pair of SGH). For measurements of Leishmania lesions, the
largest diameter was recorded on a weekly basis. Ear thickness and
lesion diameter were measured using a Digimatic caliper
(Mitutoyo Corp.).
Parasite load
Total genomic DNA was extracted from mice ears using the
DNeasy tissue kit following the manufacturer’s protocol (Qiagen).
A total of 100 ng was amplified by real time PCR (LightCycler
480, Roche Diagnostics) using primers JW11 and JW12 [16] and
18S primers as a housekeeping gene with the FastStart Sybr green
I kit (Roche). The standard curve was generated using DNA from
naı ¨ve ears spiked with 10-fold serial dilutions of L. major DNA.
Expression levels were normalized to 18S DNA and corrected for
the weight of the whole ear. Values represent the relative number
of parasites per ear.
Intracellular Cytokines
Cells were recovered from the ear dermis as described
previously [6]. Cells (5610
6) were stimulated with or without
100 mg soluble Leishmania antigen (SLA) for 12 hours. The cells
were then stimulated with 20 ng PMA and 500 ng ionomycin, in
the presence of monensin (2 mM final concentration) for 4 hours.
For surface markers, cells were washed, incubated for 15 min at
4uC with 2.4G2 mAb to block FccR, and stained with APC-Cy7
aCD4 (RM4-5) and APC-TCRb chain (H57-597) for 20 min at
4uC. The cells were fixed, permeabilized (Cytofix/Cytoperm Plus;
BD Pharmingen) and stained with PE-Cy7 aIFN-c (XMG 1.2)
and PE aIL-4 (11B11).The data were collected using a
FACSArray (BD Biosciences) and analyzed with FlowJo software
(Tree Star). The lymphocytes were gated using size, granularity
and surface markers.
GEArray
Expression profile of cytokines, chemokines, and related
inflammatory genes was generated using the mouse inflammatory
cytokines and receptor Oligo GEArray (OMM-011; Superarray).
This array contains 112 genes representing cytokines, receptors
and housekeeping genes. Two hours after challenge, total RNA
was isolated from the left ears using QIAshredder (Qiagen) and
RNeasy Mini Kit (Qiagen) following the manufacturer’s instruc-
Author Summary
In vector-borne diseases, the role of vectors has been
overlooked in the search for vaccines. Nonetheless, there is
a body of evidence showing the importance of salivary
proteins of vectors in pathogen transmission. Leishmani-
asis is a neglected vector-borne disease transmitted by
sand flies. Pre-exposure to sand fly saliva or immunization
with a salivary protein protected mice against cutaneous
leishmaniasis. Using DNA immunization we investigated
the immune response induced by abundant proteins
within the saliva of the sand fly Phlebotomus papatasi.
We found that one salivary protein protected while
another exacerbated L. major infection, suggesting that
the type of immune response induced by specific salivary
proteins can prime and direct anti-Leishmania immunity.
This stresses the importance of the proper selection of
vector-based vaccine candidates. This work validates the
powerful protection that can be acquired through
vaccination with the appropriate salivary molecule and
more importantly, shows that this protective immune
response is efficiently recalled by sand fly bites, the natural
route of transmission.
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labeled with biotin 16-UTP (Roche Diagnostics) using the
SuperArray TrueLabeling-RT Enzyme kit (Superarray). The
resulting biotinylated cRNA was hybridized overnight to the
Oligo GEArrayH membrane. After washing and blocking the array
membranes, alkaline phosphatase-conjugated streptavidin was
added to the membrane followed by CDP-Star substrate. A
chemiluminescent signal was acquired using the Image Station
2000 MM (Kodak). The data was analyzed using the GEArray
Expression Analysis Suite (Superarray). Analysis parameters were
set to local background correction and normalized to a set of
housekeeping genes included in each membrane. Results were
expressed as the fold increase in the intensity of the captured signal
over the levels in naı ¨ve ears challenged with SGH-LM. Only genes
showing a four-fold or higher change in expression compared to
the naı ¨ve group in at least two of three independent experiments
were considered.
GEArray Validation
The genes that showed a four-fold or higher change in
expression over control using the GEArray were validated by
Real time PCR. Five mg of total RNA from mice ears was used for
the synthesis of cDNA (Superscript III, Invitrogen) following the
manufacturer’s instructions. The cDNA was amplified with the
480 Master SYBR Green I mix (Roche Diagnostics) and gene
specific primer sets for IFN-c, IL-4, IL-5, TNF-a and IL-12Rb2
(Superarray) using the LightCycler 480 (Roche Diagnostics). A
standard curve for each set of primers was generated as
recommended by the manufacturer. The expression levels of the
genes of interest were normalized to endogenous 18S RNA levels.
The results are expressed in fold change over naive ears challenged
with SGH-LM.
Statistical analysis
Statistical evaluation of the means of experimental groups was
done using one-way analysis of variance followed by the Tukey-
Kramer post-test. Data from parasite numbers were log trans-
formed before conducting statistical tests. Significance was
determined as p,0.05. All statistical tests and graphs were done
using Prism-GraphPad version 5 (GraphPad Software Inc.).
Results
Immunization with PpSP15, PpSP42 and PpSP44 salivary
proteins induces a specific DTH response
Of 10 different DNA plasmids coding for the most abundant P.
papatasi salivary proteins [14,17], PpSP12 (12-kDa protein;
AF335485), PpSP14 (14-kDa protein; AF335486), PpSP15 (15-
kDa protein; AF335487), PpSP28 (28-kDa protein; AF335488),
PpAg5 (29-kDa protein; ABA54266), PpSP30 (30-kDa protein;
AF335489), PpSP32 (32-kDa protein; AF335490), PpSP36 (36-
kDa protein; AF261768), PpSP42 (42-kDa protein; AF335491),
and PpSP44 (44-kDa protein; AF335492), only mice immunized
with PpSP15, PpSP42 and PpSP44 DNA plasmids showed a
statistically significant (p,0.05) DTH response 48 hours following
challenge with SGH as measured by D ear thickness compared to
control DNA-immunized mice (CTL DNA) (Fig. 1). However,
immunization with PpSP12, PpSP14, PpAg5, PpSp32 and
PpSP36 produced humoral responses (data not shown) indicating
in vivo expression of the corresponding proteins. PpSP15 is a
15 kDa salivary protein of unknown function present only in sand
flies [14,17]. PpSP42 and PpSP44 are salivary proteins that belong
to the Yellow family of proteins [17] with a predicted molecular
weight of 42 and 44 kDa respectively.
DNA immunization with distinct DTH-inducing salivary
proteins can either promote or protect against L. major
infection
Immunization with PpSP15 DNA or protein was previously
shown to produce a DTH response and to protect animals from L.
major infection [14]. Here we reaffirm the protective nature of
PpSP15 but show that immunization with PpSP42 and PpSP44,
the remaining DTH-inducing molecules, do not confer protection
against L. major infection (Fig. 2). As predicted SGH or pre-
exposure to uninfected sand fly bites also control L. major infection
up to nine weeks post-challenge (Fig. 2). Mice immunized with
PpSP44 exacerbated the infection showing progressive lesions that
were predominantly ulcerative. The lesion size in this group was
not measured beyond week seven due to extensive tissue damage
(Fig. 2). This group was chosen for comparison to protected
PpSP15-immunized mice for a better understanding of the
Figure 1. DNA immunization with PpSP15, PpSP42 and PpSP44 induces a DTH response after challenge with SGH. C57BL/6 mice were
immunized three times at two week intervals with DNA plasmids coding for ten Phlebotomus papatasi salivary proteins, SGH and CTL DNA in the right
ear. Two weeks later the left ear was challenged intradermally with 0.5 pairs of SGH. The DTH response was assessed using D ear thickness (ear
thickness of experimental groups subtracted from the mean ear thickness of naı ¨ve mice) 48 hours after injection with 0.5 pairs of SGH. Bars represent
the mean D ear thickness for 15 mice per group 6 the SEM. Asterisks indicate statistical differences (p,0.05) compared to CTL DNA-immunized mice.
doi:10.1371/journal.pntd.0000226.g001
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infection.
PpSP15-immunized mice show a three log reduction in
parasite load compared to PpSP44-immunized mice
following challenge with SGH-LM
The parasite load was investigated at 2, 6, 9 and 11 weeks post-
infection in PpSP15- and PpSP44-immunized mice. By 6 weeks
post-infection, a significant decrease in parasite load was observed
in mice immunized with PpSP15 compared with control DNA or
PpSP44-immunized mice (data not shown). PpSP15-immunized
mice maintained a 3 log reduction in parasite load up to 11 weeks
post-infection. Panels A–C show representative ears of PpSP44-,
PpSP15- and control DNA-immunized mice, respectively,
11 weeks post-infection (Fig. 3). Overall, the ears of PpSP15-
immunized mice (Panel B) showed little to no tissue damage while
those of PpSP44-immunized mice showed severe tissue erosion
(Panel A). The ears of mice immunized with control DNA (Panel
C) were intermediate showing ulcerated lesions with moderate
tissue damage. Interestingly, the parasite loads were comparable in
mice immunized with PpSP44 and control DNA, suggesting that
the number of parasites in the ear of PpSp44-immunized animals
was not entirely responsible for the extensive damage observed in
these animals.
PpSP15-immunized mice produced four-fold higher IFN-
c and three-fold lower IL-4 compared to PpSP44-
immunized mice two weeks following challenge with
SGH-LM
The observed protection and exacerbation of L. major infection
in PpSP15- and PpSP44-immunized mice, respectively, correlates
with the expression of IFN-c and IL-4 by CD4
+ T cells recovered
from the ears of these mice two weeks after challenge with SGH-
LM (Fig. 4). Following in vitro stimulation with soluble
Leishmania antigen (SLA), 31.5% of CD4
+ T cells in PpSP15-
immunized mice produced IFN-c compared to only 7.1% and
7.8% in mice immunized with PpSP44 and control DNA
respectively (Fig. 4, top panels). IL-4 production was low in
PpSP15-immunized mice (2.5% of CD4
+ T cells). In comparison,
8.2% and 6.3% of CD4
+ T cells produced IL-4 in mice
immunized with PpSP44 and control DNA, respectively (Fig. 4,
bottom panels). These data suggest that the immune response to
distinct salivary proteins has a polarizing effect on the outcome of
Leishmania infection.
Differential induction of inflammatory transcripts in the
ear of animals immunized with PpSP15 and PpSP44 two
hours following challenge with SGH-LM
To understand the basis of the different outcomes of L. major
infection in mice immunized with PpSP15 and PpSP44 we
compared the early mRNA expression profiles of the inflammatory
cytokines in the ears of these mice two hours following challenge
with SGH-LM. Using the ‘‘Inflammatory Cytokines and Recep-
tors’’ macroarray, transcripts showing a four-fold or higher change
in signal intensity of gene expression compared to naı ¨ve controls
were further analyzed and are presented in Table 1. PpSp15-
immunized mice consistently produced high levels of IFN-c and IL-
12-Rb2 and low levels of IL-4 and IL-5 (Table 1). In contrast,
PpSP44-immunized miceproduced high levels of IL-4 and IL-5 and
baseline levels of IFN-c transcripts. TNF-a transcripts were present
at relatively high levels in mice immunized with PpSP15 and
PpSP44 (Table 1). Real-time PCR was used to validate the results of
the macroarray and showed that PpSP15-immunized animals
Figure 2. DNA immunization with distinct DTH-inducing salivary proteins modulates the course of infection with L. major. Mice
immunized in the right ear with CTL DNA ($), PpSP15 (#), PpSP42 (%), PpSP44 (&), SGH (m) or pre-exposed to bites of uninfected sand flies (.)
were challenged in the left ear with 500 L. major metacyclics and 0.5 pairs of SGH. Due to the extensive ulceration of the ears in mice immunized with
PpSP44, lesion size measurements could not be performed beyond seven weeks after challenge. The symbols represent the mean 6 the SEM for ten
mice per group. Asterisks indicate statistical significance (p,0.05) compared to mice immunized with CTL DNA. Data are representative of three
different experiments.
doi:10.1371/journal.pntd.0000226.g002
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compared to mice immunized with PpSP44 (p,0.05) (Fig. 5).
Conversely, mice immunized with PpSP44 showed a 20-fold
increase in the expression of IL-4 (p,0.005) and no significant
expression of IFN-c and IL-12-Rb2 (Fig. 5). No significant
difference was observed in the expression of IL-5 or TNF-a.
Mice immunized with PpSP15 and PpSP44 differentially
induce IFN-c and IL-4 in response to uninfected sand fly
bites
The amount of each salivary protein injected by sand flies
during feeding is unknown. Therefore, we investigated whether
the early induction of IFN-c and IL-4 in mice immunized with
PpSP15 and PpSP44, observed by challenge with SGH-LM, is
reproducible by challenge with sand fly bites. In addition,
uninfected sand flies were used to demonstrate that this response
remains unchanged in the absence of parasites. Two hours
following uninfected sand fly bites, mice immunized with PpSP15
showed a three-fold higher expression of IFN- c and a five-fold
lower expression of IL-4 compared with PpSP44-immunized mice
(Fig. 6). There were no significant differences in the expression of
IL-12Rb2 or IL-5 amongst mice immunized with PpSP15,
PpSP44 and control DNA (data not shown). This response shows
that an adaptive immune response specific to distinct salivary
proteins is inducible as early as two hours following sand fly bites
and that the amount of salivary protein injected by the bite of a
sand fly is sufficient to produce a specific and strong recall response
in immunized animals.
Discussion
It is established that a Th1 immune response and the
production of IFN-c are correlated with protection from L. major
infection in C57BL/6 mice [18]. Conversely, a Th2 immune
response is associated with susceptibility [18]. Earlier studies have
demonstrated the potential of immunity to sand fly saliva in the
control of Leishmania infection [6,7,13,14]. More information is
needed to define the immune profile induced by distinct salivary
proteins and its specific effect on the outcome of disease. In this
work, we demonstrate that DTH-inducing P. papatasi sand fly
salivary molecules are not universally protective against L. major
infection and that immunity to some can result in its exacerbation.
Mice immunized with PpSP15 controlled the infection and had
significantly lower parasite load compared to naı ¨ve mice, as
previously reported [14]. In contrast, mice immunized with
PpSP44 exacerbated the infection showing lesions with severe
tissue erosion and maintaining a high number of parasites up to
11 weeks post-infection. This is the first account in which an
immune response to a defined sand fly salivary protein results in
disease exacerbation. Protection in PpSP15-immunized mice and
exacerbation in PpSP44-immunized mice were correlated with an
anti-Leishmania Th1 and Th2 immune response, respectively
(Fig. 4). The anti-Leishmania immune response was characterized
by a considerable increase in IFN-c producing CD4
+ T cells in
PpSP15-immunized mice (over four-fold higher compared to
control DNA- and PpSP44-immunized mice) and over three-fold
lower IL-4 producing CD4
+ T cells compared to PpSP44-
immunized mice (Fig. 4). At this time point a small increase in
the percent of CD4
+ T cells producing IL-4 in PpSP44-immunized
mice was detected compared to controls. Nevertheless, there is
clear exacerbation both in lesion size and tissue pathology in
PpSP44-immunized mice (Fig. 2, 3). We propose that the
polarization of anti-Leishmania immunity towards a Th1 or Th2
response in these mice is the result of their prior immunization
with DNA encoding the respective salivary proteins. Earlier studies
have hypothesized that anti-saliva immunity leads to protection
Figure 3. Protection or exacerbation of L. major infection in mice immunized with PpSP15 or PpSP44. Mice immunized with PpSP15,
PpSP44 or CTL DNA were challenged with 500 L. major metacyclics and 0.5 pairs of SGH. The graph shows the number of parasites per ear at
11 weeks post-challenge as measured by Real time PCR. This result is representative of the parasite load at six and nine weeks post-challenge. Bars
represent the mean 6 the SEM for ten mice per group. Panels A–C reflect the pathology of the ears 11 weeks post-challenge in mice previously
immunized with PpSP44 (A), PpSP15 (B) and CTL DNA (C). Asterisks indicate significance compared to mice immunized with CTL DNA (p,0.05). Data
are representative of three independent experiments.
doi:10.1371/journal.pntd.0000226.g003
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parasite, acceleration and priming of the anti-Leishmania
immunity, or a combination of both [7,14]. Indeed, mice
protected from L. major infection through pre-exposure to sand
fly bites showed an increase in the frequency of ear epidermal cells
producing IFN-c and IL-12 six hours after challenge [7]. This
rapid production of IFN-c prompted us to investigate the
expression profile of pro-inflammatory cytokines induced by
PpSP15 and PpSP44 at an early time point (two hours) following
challenge with SGH-LM. Macroarray results validated by real-
time PCR showed that mice immunized with PpSP15 selectively
induced transcripts associated with a Th1 immune response (IFN-
c and IL-12rb2) and downregulated Th2 associated transcripts
(IL-4). IL-12rb2 is expressed on both activated Th1 CD4
+ cells
and NK cells [19–21]. Recently, it has been shown that NK cells
could play a role in adaptive immunity [22] and may be the source
of the early IFN-c expression seen in PpSP15-immunized mice.
Alternately, we cannot exclude the possibility that the up-
regulation of IFN-c expression is by specific CD4 memory T cells
that are rapidly recruited to the site of infection. The cells that are
responsible for the expression of IFN-c at this early time point is
currently under investigation. PpSP44- immunized mice that
exacerbated L. major infection selectively induced IL-4 (a marker of
Th2 differentiation) and did not upregulate IFN-c showing the
specificity of the observed immune responses to each of the
salivary proteins. It should be noted that neither IFN-c nor IL-4
were induced in the CTL DNA-immunized mice. Enhancement of
Figure 4. Frequency of CD4
+-T cells producing IFN-c or IL-4 in mice immunized with PpSP15 or PpSP44. Mice immunized in the right ear
with CTL DNA, PpSP44 or PpSP15 were challenged in the left ear with 500 L. major metacyclics and 0.5 pairs of SGH. Two weeks after challenge, the
percentage of CD4
+ T cells producing IFN-c or IL-4 were determined in cells recovered from the ear dermis (pools of three to five ears). Twelve hours
after stimulation with SLA, cells were incubated for four hours with monensin, PMA and ionomycin and stained with CD4, TCRb, IFN-c and IL-4. The
numbers represent the percentage of positive events. Data are representative of three independent experiments.
doi:10.1371/journal.pntd.0000226.g004
Table 1. Fold change in signal intensity of gene expression of
inflammatory transcripts two hours following challenge with
SGH-LM.
Transcripts PpSP15 PpSP44
Exp1 Exp2 Exp3 Exp1 Exp2 Exp3
IFN-c 5.73 10.5 2.55 1.02 1.00 1.36
IL-12Rb2 6.26 1.72 4.02 1.17 1.00 1.00
TNF 8.71 1.68 11.95 6.91 3.72 1.42
IL-4 0.33 0.33 0.17 4.84 1.15 9.14
IL-5 0.64 0.53 0.19 2.9 5.2 3.49
doi:10.1371/journal.pntd.0000226.t001
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recently demonstrated for Lu. intermedia and L. braziliensis in a
BALB/c model of infection [23]. Mice immunized with SGH of
Lu. intermedia showed a low IFN-c to IL-4 ratio that correlated with
an enhanced disease profile [23]. It is possible that the
immunodominant protein in the salivary repertoire of Lu. intermedia
induces an immune response similar to that of PpSP44 resulting in
the exacerbation of L. braziliensis infection in BALB/c mice. This is
in contrast to the protection from L. major infection observed in
BALB/c mice pre-exposed to P. papatasi bites or SGH [6,7].
Interestingly, the molecular weight of a strongly antigenic salivary
protein of Lu. intermedia is 45 kDa [23] corresponding to the
molecular weight of PpSP44. This raises the question whether
immuno-dominance of salivary proteins vary in different sand fly
species. Saliva is composed of a repertoire of proteins and their
overall effect is likely influenced by the sand fly species, the
Leishmania species and the mammalian host resulting in an
overriding exacerbative or protective immune profile. Stimulatory
and suppressive immune responses to salivary molecules have been
previously described in ticks [24]. Lymphocytes from tick resistant
donors proliferated in response to tick salivary gland antigens
demonstrating antigen-specific stimulation. However, their non-
specific PHA-induced proliferation was significantly suppressed
[24].
Since Leishmania is transmitted by sand fly bites we wanted to
verify if the small amount of PpSP15 or PpSP44 injected by sand
flies during feeding is able to recall the same level and type of
immunity observed in response to challenge with SGH-LM.
Moreover, we used uninfected sand flies to investigate whether this
response is specific to the salivary molecules and is not influenced
by the presence of Leishmania parasites in SGH-LM. Sand fly
bites induced an early up-regulation of IFN-c in PpSP15-
immunized mice suggesting that this salivary protein can recall a
protective Th1 response by the natural route of exposure. PpSP44-
Figure 5. Early expression of cytokines after challenge with SGH-LM in CTL DNA, PpSP15- or PpSP44-immunized mice. Two hours
after challenge with 500 L. major metacyclics and 0.5 pairs of SGH, expression of IFN-c and IL-12Rb2 was induced in mice immunized with PpSP15. In
contrast, mice immunized with PpSP44 induced the expression of IL-4. Relative mRNA expression was determined by real time PCR and normalized to
the18S housekeeping gene. Values represent the fold increase over naı ¨ve mice after challenge with SGH-LM. Bars represent the mean 6 the SEM for
24 mice per group. Asterisks indicate statistical significance (p,0.05) between the PpSP15 and the PpSP44 experimental groups. Data represent the
combined outcome of three independent experiments.
doi:10.1371/journal.pntd.0000226.g005
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challenge with SGH-LM and maintained a high expression of IL-4
and a low expression of IFN-c (Fig. 6). Despite the fact that the
above responses were elicited by uninfected sand fly bites, infected
flies are expected to inject more saliva as a result of difficulty in
feeding and increased probing activity [25–27]. This further
confirms that an immune response specific to a salivary antigen
that generates a DTH response with a Th1 profile is able to confer
protection against L. major infection, independent of other
confounding factors present in the complex feeding behavior of
the sand fly. Recently, Vinhas et al. [28] demonstrated that
PBMCs from normal volunteers pre-exposed to the bites of
uninfected Lu. longipalpis produced IFN-c following stimulation
with SGH. IFN-c production was also correlated with killing of L.
chagasi parasites in a macrophage-lymphocyte autologous culture
[28]. This demonstrates for the first time that humans can mount
an anti-saliva cellular immune response that correlates with
protection from Leishmania infection and emphasizes the need to
identify the molecules in saliva that are responsible for this effect.
Currently, there is no evidence that humans will mount a cellular
immune response to either PpSP44 or PpSP15 proteins. Further
studies are needed to elucidate the role of these salivary proteins in
endemic areas.
Overall, these data suggest that the early induction of a distinct
Th1-type immune response by salivary proteins is important for
priming a protective immune response against Leishmania
infection. Moreover, a DTH response to saliva or a salivary
antigen by itself cannot be considered as a correlate of protection
against Leishmania infection.
In conclusion, this paper clearly demonstrates that immuniza-
tion with a particular salivary protein can have a profound
modulatory effect on Leishmania infection. We believe that this
immunization acts through the differential priming of anti-
Leishmania immunity resulting in protection or susceptibility to
disease.
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